Mabpharm Ltd.

  • Market Cap: N/A
  • Industry: Miscellaneous
  • ISIN: KYG5780F1046
HKD
0.44
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
700.71
279.98
96.31
65.03
99.89
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
700.71
279.98
96.31
65.03
99.89
0.00
0.00
Raw Material Cost
120.05
93.56
70.36
68.62
70.18
27.41
25.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
67.28
77.98
93.94
116.17
107.66
76.56
77.85
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
11.72
11.44
10.58
8.36
2.90
4.43
8.73
Selling and Distribution Expenses
520.59
244.09
126.81
107.98
87.11
56.41
55.08
Other Expenses
-2.42
-1.73
1.73
2.70
19.06
4.44
5.67
Total Expenditure (Excl Depreciation)
695.50
409.73
319.03
328.13
458.47
209.25
223.54
Operating Profit (PBDIT) excl Other Income
5.2
-129.8
-222.7
-263.09999999999997
-358.6
-209.20000000000002
-223.5
Other Income
7.66
2.18
2.06
25.97
9.86
6.21
33.83
Operating Profit (PBDIT)
81.00
-61.08
-153.59
-177.18
-295.84
-175.63
-164.54
Interest
11.72
11.44
10.58
8.36
2.90
4.43
8.73
Exceptional Items
0.07
0.29
-0.09
0.33
0.00
0.00
-31.21
Gross Profit (PBDT)
580.66
186.42
25.96
-3.60
29.71
-27.41
-25.17
Depreciation
64.83
66.49
67.07
59.95
52.88
27.41
25.17
Profit Before Tax
4.51
-138.72
-231.34
-245.16
-351.61
-207.47
-229.65
Tax
-57.45
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
61.96
-138.72
-231.34
-245.16
-351.61
-207.47
-229.65
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
61.96
-138.72
-231.34
-245.16
-351.61
-207.47
-229.65
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
61.96
-138.72
-231.34
-245.16
-351.61
-207.47
-229.65
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
175.21
94.64
225.77
450.16
736.38
1,045.12
1,178.68
Earnings per share (EPS)
0.01
-0.03
-0.06
-0.06
-0.09
-0.05
-0.06
Diluted Earnings per share
0.01
-0.03
-0.06
-0.06
-0.09
-0.05
-0.06
Operating Profit Margin (Excl OI)
1.21%
-46.34%
-231.25%
-404.61%
-358.97%
0.0%
0.0%
Gross Profit Margin
9.9%
-25.8%
-170.56%
-284.83%
-299.06%
0.0%
0.0%
PAT Margin
8.84%
-49.55%
-240.19%
-377.01%
-352.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 150.25% vs 190.76% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 144.70% vs 40.03% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 215.80% vs 59.34% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 2.63% vs 7.55% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Mabpharm Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
700.71
2,700.03
-1,999.32
-74.05%
Other Operating Income
0.00
0.00
0.00
Total Operating income
700.71
2,700.03
-1,999.32
-74.05%
Raw Material Cost
120.05
1,573.40
-1,453.35
-92.37%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
67.28
644.02
-576.74
-89.55%
Power Cost
0
0
0.00
Manufacturing Expenses
11.72
33.44
-21.72
-64.95%
Selling and Distribution Expenses
520.59
172.53
348.06
201.74%
Other Expenses
-2.42
-67.75
65.33
96.43%
Total Expenditure (Excl Depreciation)
695.50
1,745.93
-1,050.43
-60.16%
Operating Profit (PBDIT) excl Other Income
5.21
954.10
-948.89
-99.45%
Other Income
7.66
96.18
-88.52
-92.04%
Operating Profit (PBDIT)
81.00
1,851.33
-1,770.33
-95.62%
Interest
11.72
33.44
-21.72
-64.95%
Exceptional Items
0.07
-45.41
45.48
100.15%
Gross Profit (PBDT)
580.66
1,126.63
-545.97
-48.46%
Depreciation
64.83
801.05
-736.22
-91.91%
Profit Before Tax
4.51
971.42
-966.91
-99.54%
Tax
-57.45
-10.27
-47.18
-459.40%
Provisions and contingencies
0
0
0.00
Profit After Tax
61.96
976.56
-914.60
-93.66%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
61.96
976.56
-914.60
-93.66%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
5.13
-5.13
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
61.96
981.69
-919.73
-93.69%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
175.21
9,606.37
-9,431.16
-98.18%
Earnings per share (EPS)
0.01
0.24
-0.23
-95.83%
Diluted Earnings per share
0.01
0.24
-0.23
-95.83%
Operating Profit Margin (Excl OI)
1.21%
35.34%
0.00
-34.13%
Gross Profit Margin
9.90%
65.65%
0.00
-55.75%
PAT Margin
8.84%
36.17%
0.00
-27.33%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 70.07 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 150.25% vs 190.76% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 6.20 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 144.70% vs 40.03% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.33 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 215.80% vs 59.34% in Dec 2024

Annual - Interest
Interest 1.17 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 2.63% vs 7.55% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.21%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024